Results 41 to 50 of about 1,693,659 (204)
Platelets, 2022 In 2021, the world experienced the most extensive vaccination campaign to defeat COVID-19. Many cases of idiopathic thrombocytopenia have been reported following injections of SARS-Cov-2 mRNA vaccine.
Mathilde Chanut +7 more
doaj +1 more source
mRNA Vaccines against Flaviviruses [PDF]
Vaccines, 2021 Numerous vaccines have now been developed using the mRNA platform. In this approach, mRNA coding for a viral antigen is in vitro synthesized and injected into the host leading to exogenous protein expression and robust immune responses. Vaccines can be rapidly developed utilizing the mRNA platform in the face of emerging pandemics.
Clayton J. Wollner, Justin M. Richner
openaire +3 more sources
Vaccines, 2021 The mRNA-based vaccine approach is a promising alternative to traditional vaccines due to its ability for prompt development, high potency, and potential for secure administration and low-cost production.
Md. Motiar Rahman +2 more
doaj +1 more source
The advances of adjuvants in mRNA vaccines
npj Vaccines, 2023 AbstractThe remarkable success of messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has propelled the rapid development of this vaccination technology in recent years. Over the last three decades, numerous studies have shown the considerable potential of mRNA vaccines that elicit protective immune ...
Chunyuan Xie, Ruhui Yao, Xiaojun Xia
openaire +3 more sources
Pharmaceutics, 2022 The vaccine distribution chains in several low- and middle-income countries are not adequate to facilitate the rapid delivery of high volumes of thermosensitive COVID-19 mRNA vaccines at the required low and ultra-low temperatures. COVID-19 mRNA vaccines
Zoltán Kis
doaj +1 more source
Advances in COVID-19 mRNA vaccine development
Signal Transduction and Targeted Therapy, 2022 To date, the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has determined 399,600,607 cases and 5,757,562 deaths worldwide. COVID-19 is a serious threat to human health globally.
Enyue Fang +9 more
semanticscholar +1 more source
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel
New England Journal of Medicine, 2021 Background Approximately 5.1 million Israelis had been fully immunized against coronavirus disease 2019 (Covid-19) after receiving two doses of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) by May 31, 2021.
D. Mevorach +26 more
semanticscholar +1 more source
Vaccines, 2023 Safety data following the COVID-19 booster mRNA vaccine in solid cancer patients are scarce. We prospectively evaluated adverse events after a booster dose of the BNT162b2 vaccine as compared to the mRNA-1273 vaccine in solid malignancy patients who had ...
Passakorn Wanchaijiraboon +10 more
doaj +1 more source
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
Nature Medicine, 2021 In a cohort of BNT162b2 (Pfizer–BioNTech) mRNA vaccine recipients (n = 1,090), we observed that spike-specific IgG antibody levels and ACE2 antibody binding inhibition responses elicited by a single vaccine dose in individuals with prior SARS-CoV-2 ...
J. Ebinger +11 more
semanticscholar +1 more source
A Comprehensive Review of mRNA Vaccines
International Journal of Molecular Sciences, 2023 mRNA vaccines have been demonstrated as a powerful alternative to traditional conventional vaccines because of their high potency, safety and efficacy, capacity for rapid clinical development, and potential for rapid, low-cost manufacturing. These vaccines have progressed from being a mere curiosity to emerging as COVID-19 pandemic vaccine front ...
Vrinda Gote +6 more
openaire +2 more sources